404 related articles for article (PubMed ID: 21501294)
1. High expression of L-type amino-acid transporter 1 (LAT1) in gastric carcinomas: comparison with non-cancerous lesions.
Ichinoe M; Mikami T; Yoshida T; Igawa I; Tsuruta T; Nakada N; Anzai N; Suzuki Y; Endou H; Okayasu I
Pathol Int; 2011 May; 61(5):281-9. PubMed ID: 21501294
[TBL] [Abstract][Full Text] [Related]
2. L-Type amino acid transporter 1 (LAT1) expression in lymph node metastasis of gastric carcinoma: Its correlation with size of metastatic lesion and Ki-67 labeling.
Ichinoe M; Yanagisawa N; Mikami T; Hana K; Nakada N; Endou H; Okayasu I; Murakumo Y
Pathol Res Pract; 2015 Jul; 211(7):533-8. PubMed ID: 25908107
[TBL] [Abstract][Full Text] [Related]
3. L-type amino acid transporter 1 expression is a prognostic marker in patients with surgically resected stage I non-small cell lung cancer.
Imai H; Kaira K; Oriuchi N; Yanagitani N; Sunaga N; Ishizuka T; Kanai Y; Endou H; Nakajima T; Mori M
Histopathology; 2009 Jun; 54(7):804-13. PubMed ID: 19635099
[TBL] [Abstract][Full Text] [Related]
4. High expression of L-type amino acid transporter 1 (LAT1) predicts poor prognosis in pancreatic ductal adenocarcinomas.
Yanagisawa N; Ichinoe M; Mikami T; Nakada N; Hana K; Koizumi W; Endou H; Okayasu I
J Clin Pathol; 2012 Nov; 65(11):1019-23. PubMed ID: 22813728
[TBL] [Abstract][Full Text] [Related]
5. Paradoxical expression of maspin in gastric carcinomas: correlation with carcinogenesis and progression.
Yu M; Zheng H; Tsuneyama K; Takahashi H; Nomoto K; Xu H; Takano Y
Hum Pathol; 2007 Aug; 38(8):1248-55. PubMed ID: 17490717
[TBL] [Abstract][Full Text] [Related]
6. Expression of cyclin-dependent kinase inhibitor p21WAF1/CIP1 in non-neoplastic mucosa and neoplasia of the stomach: relationship with p53 status and proliferative activity.
Yasui W; Akama Y; Kuniyasu H; Yokozaki H; Semba S; Shimamoto F; Tahara E
J Pathol; 1996 Oct; 180(2):122-8. PubMed ID: 8976868
[TBL] [Abstract][Full Text] [Related]
7. Relationship between LAT1 expression and response to platinum-based chemotherapy in non-small cell lung cancer patients with postoperative recurrence.
Kaira K; Takahashi T; Murakami H; Shukuya T; Kenmotsu H; Naito T; Oriuchi N; Kanai Y; Endo M; Kondo H; Nakajima T; Yamamoto N
Anticancer Res; 2011 Nov; 31(11):3775-82. PubMed ID: 22110199
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of GRP78 and GRP94 are markers for aggressive behavior and poor prognosis in gastric carcinomas.
Zheng HC; Takahashi H; Li XH; Hara T; Masuda S; Guan YF; Takano Y
Hum Pathol; 2008 Jul; 39(7):1042-9. PubMed ID: 18482745
[TBL] [Abstract][Full Text] [Related]
9. CD98 expression is associated with poor prognosis in resected non-small-cell lung cancer with lymph node metastases.
Kaira K; Oriuchi N; Imai H; Shimizu K; Yanagitani N; Sunaga N; Hisada T; Kawashima O; Kamide Y; Ishizuka T; Kanai Y; Nakajima T; Mori M
Ann Surg Oncol; 2009 Dec; 16(12):3473-81. PubMed ID: 19777189
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of L-type amino acid transporter 1 (LAT1) and 4F2 heavy chain (CD98) expression in stage I pulmonary adenocarcinoma.
Kaira K; Oriuchi N; Imai H; Shimizu K; Yanagitani N; Sunaga N; Hisada T; Ishizuka T; Kanai Y; Nakajima T; Mori M
Lung Cancer; 2009 Oct; 66(1):120-6. PubMed ID: 19171406
[TBL] [Abstract][Full Text] [Related]
11. Analysis of mucin, p53 protein and Ki-67 expressions in gastric differentiated-type intramucosal neoplastic lesions obtained from endoscopic mucosal resection samples: a proposal for a new classification of intramucosal neoplastic lesions based on nuclear atypia.
Sugai T; Inomata M; Uesugi N; Jiao YF; Endoh M; Orii S; Nakamura S
Pathol Int; 2004 Jun; 54(6):425-35. PubMed ID: 15144402
[TBL] [Abstract][Full Text] [Related]
12. Expression of L-type amino acid transporter 1 (LAT1) in neuroendocrine tumors of the lung.
Kaira K; Oriuchi N; Imai H; Shimizu K; Yanagitani N; Sunaga N; Hisada T; Kawashima O; Iijima H; Ishizuka T; Kanai Y; Endou H; Nakajima T; Mori M
Pathol Res Pract; 2008; 204(8):553-61. PubMed ID: 18440724
[TBL] [Abstract][Full Text] [Related]
13. Expression of L-type amino acid transporter 1 (LAT1) in esophageal carcinoma.
Kobayashi H; Ishii Y; Takayama T
J Surg Oncol; 2005 Jun; 90(4):233-8. PubMed ID: 15906366
[TBL] [Abstract][Full Text] [Related]
14. Expression of the 27-kDa heat shock protein (HSP27) in gastric carcinomas and adjacent normal, metaplastic, and dysplastic gastric mucosa, and its prognostic significance.
Kapranos N; Kominea A; Konstantinopoulos PA; Savva S; Artelaris S; Vandoros G; Sotiropoulou-Bonikou G; Papavassiliou AG
J Cancer Res Clin Oncol; 2002 Aug; 128(8):426-32. PubMed ID: 12200599
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of L-type amino acid transporter 1 (LAT1) and 4F2 heavy chain (CD98) expression in early stage squamous cell carcinoma of the lung.
Kaira K; Oriuchi N; Imai H; Shimizu K; Yanagitani N; Sunaga N; Hisada T; Ishizuka T; Kanai Y; Endou H; Nakajima T; Mori M
Cancer Sci; 2009 Feb; 100(2):248-54. PubMed ID: 19068093
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of minichromosome maintenance 2 predicts poor prognosis in patients with gastric cancer.
Yang C; Wen Y; Li H; Zhang D; Zhang N; Shi X; Jiang B; Ma X; Yang P; Tang H; Peng Z; Yang Y
Oncol Rep; 2012 Jan; 27(1):135-42. PubMed ID: 21947329
[TBL] [Abstract][Full Text] [Related]
17. l-type amino acid transporter 1 and CD98 expression in primary and metastatic sites of human neoplasms.
Kaira K; Oriuchi N; Imai H; Shimizu K; Yanagitani N; Sunaga N; Hisada T; Tanaka S; Ishizuka T; Kanai Y; Endou H; Nakajima T; Mori M
Cancer Sci; 2008 Dec; 99(12):2380-6. PubMed ID: 19018776
[TBL] [Abstract][Full Text] [Related]
18. Expression of heart-type fatty acid-binding protein in human gastric carcinoma and its association with tumor aggressiveness, metastasis and poor prognosis.
Hashimoto T; Kusakabe T; Sugino T; Fukuda T; Watanabe K; Sato Y; Nashimoto A; Honma K; Kimura H; Fujii H; Suzuki T
Pathobiology; 2004; 71(5):267-73. PubMed ID: 15459486
[TBL] [Abstract][Full Text] [Related]
19. LAT1 expression in non-small-cell lung carcinomas: analyses by semiquantitative reverse transcription-PCR (237 cases) and immunohistochemistry (295 cases).
Takeuchi K; Ogata S; Nakanishi K; Ozeki Y; Hiroi S; Tominaga S; Aida S; Matsuo H; Sakata T; Kawai T
Lung Cancer; 2010 Apr; 68(1):58-65. PubMed ID: 19559497
[TBL] [Abstract][Full Text] [Related]
20. Expression of SIRT1 in gastric cardiac cancer and its clinicopathologic significance.
Feng AN; Zhang LH; Fan XS; Huang Q; Ye Q; Wu HY; Yang J
Int J Surg Pathol; 2011 Dec; 19(6):743-50. PubMed ID: 21865267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]